Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Mar;18(3):172-8.
doi: 10.1016/j.jnutbio.2006.12.007.

Dietary calcium supplementation to lower blood lead levels in pregnancy and lactation

Affiliations
Review

Dietary calcium supplementation to lower blood lead levels in pregnancy and lactation

Adrienne S Ettinger et al. J Nutr Biochem. 2007 Mar.

Abstract

Pregnancy and lactation are states known to be accompanied by physiologically up regulated bone resorption in response to the calcium demands of the developing fetus and nursing infant. The role of calcium supplements in altering maternal responses to fetal demand for calcium is not fully understood. Exposure to the toxicant lead is known to pose a major hazard to fetal neurodevelopment and growth. Since >95% of maternal lead is stored in the bone, mobilization of cumulative maternal lead stores into the circulation represents an endogenous source of exposure, which may pose a significant hazard for the fetus and infant. Maternal dietary calcium supplementation has been associated with reductions in lead levels in both animal and human studies when administered during pregnancy and lactation. Therefore, supplementation of the maternal diet with calcium may represent an important secondary prevention strategy aimed not only at reducing circulating levels of lead in the mother but also at reducing lead exposure to the developing fetus and nursing infant.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Hormonal Control of Plasma Calcium
Note: PTH=parathyroid hormone; CT=calcitonin; 1,25(OH)2D3=vitamin D (Adapted from: Kovacs & Kronenberg, 1997)
Figure 2
Figure 2
Lead Exposure Pathway from Mother to Infant (using Mexico as an example; adapted from Chuang et al., 2001).
Figure 3
Figure 3
Potential Mechanism of Calcium Effects
Figure 4
Figure 4. Hypothesized Effects of Lead on Calcium and Vitamin D Metabolism
Note: PTH=parathyroid hormone; CT=calcitonin; 1,25(OH)2D3=1,25-dihydroxycholecalciferol (calcitriol) hormonally-active form of vitamin D; 25(OH)D3=circulating form of vitamin D

Similar articles

Cited by

References

    1. Blood lead levels--United States. MMWR Morb Mortal Wkly Rep. 1999–2002;2005;54(20):513–6. - PubMed
    1. Meyer PA, Pivetz T, Dignam TA, Homa DM, Schoonover J, Brody D. Surveillance for elevated blood lead levels among children--United States, 1997–2001. MMWR Surveill Summ. 2003;52(10):1–21. - PubMed
    1. Lanphear BP, Dietrich K, Auinger P, Cox C. Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents. Public Health Rep. 2000;115(6):521–9. - PMC - PubMed
    1. Lanphear BP, Hornung R, Khoury J, et al. Low-level environmental lead exposure and children’s intellectual function: an international pooled analysis. Environ Health Perspect. 2005;113(7):894–9. - PMC - PubMed
    1. Schwartz J. Beyond LOEL’s, p values, and vote counting: methods for looking at the shapes and strengths of associations. Neurotoxicology. 1993;14(2–3):237–46. - PubMed

Publication types